Hepatic OATP1B Transporters and Nuclear Receptors PXR and CAR: Interplay, Regulation of Drug Disposition Genes, and Single Nucleotide Polymorphisms

被引:42
作者
Schwabedissen, Henriette E. Meyer Zu [1 ,2 ]
Kim, Richard B. [2 ]
机构
[1] Univ Greifswald, Dept Pharmacol, Greifswald, Germany
[2] Univ Western Ontario, Dept Med, Div Clin Pharmacol, London, ON, Canada
关键词
Organic anion transporting polypeptide; single nucleotide polymorphism; nuclear receptor; transactivation; pregnane X receptor; constitutive androstane receptor; vitamin D receptor; farnesoid X receptor; PREGNANE-X-RECEPTOR; CONSTITUTIVE-ANDROSTANE-RECEPTOR; ORGANIC ANION TRANSPORTER; PLASMA PRAVASTATIN CONCENTRATIONS; NATURALLY-OCCURRING VARIANTS; ACTIVATED PROTEIN-KINASE; DISTAL ENHANCER MODULE; FUNCTIONAL-CHARACTERIZATION; HEPATOBILIARY TRANSPORT; GLUCOCORTICOID-RECEPTOR;
D O I
10.1021/mp9000298
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Drug uptake transporters are now increasingly recognized as clinically relevant determinants of variable drug responsiveness and unexpected drug-drug interactions. Emerging evidence strongly suggests members of the organic anion transporting polypeptide (OATP) family appear to be particularly important to the disposition of many drugs in clinical use today. Specifically, the liver-enriched OATP1B subfamily members OATP1B1 and OATP1B3 exhibit broad substrate specificity and the ability to transport drugs which are ligands for xenobiotic sensing nuclear receptors such as the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR). Accordingly, OATP1B transporters may indirectly regulate expression of drug metabolism genes via modulation of the intracellular concentration of PXR and CAR ligands. Moreover, a number of functionally important single nucleotide polymorphisms (SNPs) in OATP1B transporters have been described. In this review, a brief summary of known SNPs in PXR and CAR will be followed by an in-depth outline of OATP1B1 and OATP1B3 transporters particularly in relation to the known SNPs in these OATPs and the interplay between OATP1B transporters with PXR and CAR, both in vitro and in vivo.
引用
收藏
页码:1644 / 1661
页数:18
相关论文
共 203 条
  • [1] LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers
    Abe, T
    Unno, M
    Onogawa, T
    Tokui, T
    Kondo, TN
    Nakagomi, R
    Adachi, H
    Fujiwara, K
    Okabe, M
    Suzuki, T
    Nunoki, K
    Sato, E
    Kakyo, M
    Nishio, T
    Sugita, J
    Asano, N
    Tanemoto, M
    Seki, M
    Date, F
    Ono, K
    Kondo, Y
    Shiiba, K
    Suzuki, M
    Ohtani, H
    Shimosegawa, T
    Iinuma, K
    Nagura, H
    Ito, S
    Matsuno, S
    [J]. GASTROENTEROLOGY, 2001, 120 (07) : 1689 - 1699
  • [2] Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1
    Abe, T
    Kakyo, M
    Tokui, T
    Nakagomi, R
    Nishio, T
    Nakai, D
    Nomura, H
    Unno, M
    Suzuki, M
    Naitoh, T
    Matsuno, S
    Yawo, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) : 17159 - 17163
  • [3] Arnold Katja A, 2004, Nucl Recept, V2, P1, DOI 10.1186/1478-1336-2-1
  • [4] Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice
    Assem, M
    Schuetz, EG
    Leggas, M
    Sun, DX
    Yasuda, K
    Reid, G
    Zelcer, N
    Adachi, M
    Strom, S
    Evans, RM
    Moore, DD
    Borst, P
    Schuetz, JD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) : 22250 - 22257
  • [5] Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites
    Backman, JT
    Lulurila, H
    Neuvonen, M
    Neuvonen, PJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (02) : 154 - 167
  • [6] Nuclear receptor structure: Implications for function
    Bain, David L.
    Heneghan, Aaron F.
    Connaghan-Jones, Keith D.
    Miura, Michael T.
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 2007, 69 : 201 - 220
  • [7] Pharmacogenetic Pathway Analysis of Docetaxel Elimination
    Baker, S. D.
    Verweij, J.
    Cusatis, G. A.
    van Schaik, R. H.
    Marsh, S.
    Orwick, S. J.
    Franke, R. M.
    Hu, S.
    Schuetz, E. G.
    Lamba, V.
    Messersmith, W. A.
    Wolff, A. C.
    Carducci, M. A.
    Sparreboom, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (02) : 155 - 163
  • [8] Development of a fluorescence-based assay for screening of modulators of human Organic Anion Transporter 1B3 (OATP1B3)
    Baldes, C
    Koenig, P
    Neumann, D
    Lenhof, HP
    Kohlbacher, O
    Lehr, CM
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 62 (01) : 39 - 43
  • [9] Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps
    Ballestero, Maria R.
    Monte, Maria J.
    Briz, Oscar
    Jimenez, Felipe
    Martin, Francisco Gonzalez-San
    Marin, Jose J. G.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 72 (06) : 729 - 738
  • [10] Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7
    Bertilsson, G
    Berkenstam, A
    Blomquist, P
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (01) : 139 - 144